Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant Recipients

SEKMEK, SERHAT; YILDIRIM, TOLGA; KOÇ, NERİMAN; ÖNAL, CEREN; Jabrayilov, Jabrayil; Yilmaz, Rahmi; ARICI, MUSTAFA; ALTUN, BÜLENT; ERDEM, YUNUS

doi:10.1016/j.transproceed.2021.06.020

Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant Recipients

Atıf İçin Kopyala

SEKMEK S., YILDIRIM T., KOÇ N. S., ÖNAL C., Jabrayilov J., Yilmaz R., ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.53, sa.6, ss.1951-1956, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 53 Sayı: 6
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.transproceed.2021.06.020
Dergi Adı: TRANSPLANTATION PROCEEDINGS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
Sayfa Sayıları: ss.1951-1956
Hacettepe Üniversitesi Adresli: Evet

Özet

Background. Diarrhea is a common adverse effect of mycophenolate treatment in renal transplant recipients. In patients with mycophenolate-induced diarrhea, one option is to switch to mycophenolate to azathioprine. In this study, we aimed to define the safety and efficacy of switching from mycophenolate to azathioprine for mycophenolate-related diarrhea in renal transplant recipients.